An overview of arsenic trioxide-involved combined treatment algorithms for leukemia: basic concepts and clinical implications
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
An overview of arsenic trioxide-involved combined treatment algorithms for leukemia: basic concepts and clinical implications
Authors
Keywords
-
Journal
Cell Death Discovery
Volume 9, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2023-07-28
DOI
10.1038/s41420-023-01558-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The involvement and therapeutic potential of lncRNA Kcnq1ot1/miR-34a-5p/Sirt1 pathway in arsenic trioxide-induced cardiotoxicity
- (2023) Xiuyun Shen et al. Journal of Translational Medicine
- Acute promyelocytic leukaemia: population-based study of epidemiology and outcome with ATRA and oral-ATO from 1991 to 2021
- (2023) Harinder Gill et al. BMC CANCER
- Gemtuzumab Ozogamicin Followed by Unrelated Cord Blood Transplantation With Reduced-intensity Conditioning for a Child With Refractory Acute Promyelocytic Leukemia
- (2022) Yuji Yamada et al. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
- Real world data with concurrent retinoic acid and arsenic trioxide for the treatment of acute promyelocytic leukemia
- (2022) Uday P. Kulkarni et al. Blood Cancer Journal
- The whole transcriptome analysis and the circRNA-lncRNA network construction in arsenic trioxide-treated mice myocardium
- (2022) Yanan Jiang et al. BIOMEDICINE & PHARMACOTHERAPY
- The comparison of plasma arsenic concentration and urinary arsenic excretion during treatment with Realgar-Indigo naturalis formula and arsenic trioxide in children with acute promyelocytic leukemia
- (2022) Liu-Hua Liao et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Oral Realgar-Indigo Naturalis Formula Treatment for Acute Promyelocytic Leukemia in Children: A Randomized, Control Clinical Trial
- (2022) Senlin Luo et al. Evidence-based Complementary and Alternative Medicine
- Oral arsenic and retinoic acid for high-risk acute promyelocytic leukemia
- (2022) Ya-Fang Ma et al. Journal of Hematology & Oncology
- Oral arsenic trioxide for treating acute promyelocytic leukaemia: Implications for its worldwide epidemiology and beyond
- (2022) Cyrus R. Kumana et al. Frontiers in Oncology
- Arsenic trioxide and all-trans retinoic acid in the treatment of children with newly diagnosed acute promyelocytic leukemia
- (2021) Shuang-Yue Li et al. LEUKEMIA & LYMPHOMA
- Characteristics of arsenic species in cerebrospinal fluid (CSF) of acute promyelocytic leukemia (APL) patients treated with arsenic trioxide plus mannitol
- (2021) Meihua Guo et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- An Outcome Analysis of Childhood Acute Promyelocytic Leukemia Treated with Atra and Arsenic Trioxide, and Limited Dose Anthracycline
- (2021) Naeem Jabbar et al. INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION
- Arsenic trioxide‑induced cell apoptosis and cell cycle arrest are potentiated by 1,25‑dihydroxyvitamin D3 in human leukemia K562 cells
- (2021) Ya-Li Zhang et al. Oncology Letters
- Population Pharmacokinetics and Safety of Oral Tetra-Arsenic Tetra-Sulfide Formula in Pediatric Acute Promyelocytic Leukemia
- (2021) Li Zhang et al. Drug Design Development and Therapy
- Arsenic trioxide synergistically promotes the antileukaemic activity of venetoclax by downregulating Mcl-1 in acute myeloid leukaemia cells
- (2021) Hyunsoo Cho et al. Experimental Hematology & Oncology
- Effects of co-administration of arsenic trioxide and Schiff base oxovanadium complex on the induction of apoptosis in acute promyelocytic leukemia cells
- (2021) Sara Mirjalili et al. BIOMETALS
- PML‐RARA transcript levels at the end of induction therapy are associated with prognosis in non‐high‐risk acute promyelocytic leukaemia with all‐ trans retinoic acid plus arsenic in front‐line therapy: long‐term follow‐up of a single‐centre cohort study
- (2021) Fei‐Fei Tang et al. BRITISH JOURNAL OF HAEMATOLOGY
- Arsenic Combined With All-Trans Retinoic Acid for Pediatric Acute Promyelocytic Leukemia: Report From the CCLG-APL2016 Protocol Study
- (2021) Huyong Zheng et al. JOURNAL OF CLINICAL ONCOLOGY
- Successful treatment of acute promyelocytic leukemia in a 92-year-old man using all-trans retinoic acid combined with oral arsenic
- (2021) Xiaowei Shi et al. MEDICINE
- Efficacy and Tolerability of First Line Arsenic Trioxide in Combination With All-Trans Retinoic Acid in Patients With Acute Promyelocytic Leukemia: Real Life Experience
- (2021) Francesco Autore et al. Frontiers in Oncology
- All-trans Retinoic Acid, Arsenic Trioxide, and Anthracycline-based Chemotherapy Improves Outcome in Newly Diagnosed Acute Promyelocytic Leukemia Regardless of FLT3-ITD Mutation Status
- (2021) Lin-wei Xu et al. Current Medical Science
- Long-Term Quality of Life of Acute Promyelocytic Leukemia Patients Treated with Arsenic Trioxide versus Chemotherapy
- (2021) Fabio Efficace et al. Blood Advances
- Safety and efficacy of Compound Huangdai Tablets combined with all-trans retinoic acid for treatment of acute promyelocytic leukemia: Clinical evidence and potential mechanisms
- (2021) Qian-qian Huang et al. Chinese Herbal Medicines
- Curcumin Synergistically Enhances the Cytotoxicity of Arsenic Trioxide in U266 Cells by Increasing Arsenic Uptake
- (2021) Dingding Han et al. Evidence-based Complementary and Alternative Medicine
- Assessment of Arsenic Trioxide and All-trans Retinoic Acid for the Treatment of Pediatric Acute Promyelocytic Leukemia
- (2021) Matthew A. Kutny et al. JAMA Oncology
- The Combination of Gefitinib With ATRA and ATO Induces Myeloid Differentiation in Acute Promyelocytic Leukemia Resistant Cells
- (2021) Luciana Yamamoto de Almeida et al. Frontiers in Oncology
- Treatment of non-high-risk acute promyelocytic leukemia with realgar-indigo naturalis formula (RIF) and all-trans retinoid acid (ATRA): study protocol for a randomized controlled trial
- (2020) Xinxin Zhang et al. Trials
- Oral arsenic trioxide, all‐ trans retinoic acid, and ascorbic acid maintenance after first complete remission in acute promyelocytic leukemia: Long‐term results and unique prognostic indicators
- (2020) Harinder S. Gill et al. CANCER
- Sequential Treatment of Arsenic Trioxide Followed by All Trans Retinoic Acid with Anthracyclines has Excellent Long-Term Cure in Acute Promyelocytic Leukemia
- (2020) Santhosh Kumar Devadas et al. INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION
- Resurrection of Oral Arsenic Trioxide for Treating Acute Promyelocytic Leukaemia: A Historical Account From Bedside to Bench to Bedside
- (2020) Cyrus R. Kumana et al. Frontiers in Oncology
- Targeting FLT3 mutations in AML: review of current knowledge and evidence
- (2019) Naval Daver et al. LEUKEMIA
- Acute myeloid leukemia in an 86-year-old man with AML1/ETO treated with Homoharringtonine and Arsenic Trioxide
- (2019) Zhipeng He et al. MEDICINE
- Successful Treatment With ATRA and Arsenic Trioxide for a Child With Down Syndrome and Acute Promyelocytic Leukemia
- (2019) Yusuke Tsumura et al. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
- Venetoclax-based Therapies for Acute Myeloid Leukemia
- (2019) Veronica A. Guerra et al. BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
- Efficacy and safety of early switching to an outpatient therapy model using oral arsenic plus retinoic acid based-regimen in newly diagnosed acute promyelocytic leukemia
- (2019) Yinjun Lou et al. LEUKEMIA RESEARCH
- Downregulation of Long Non-Coding RNA Kcnq1ot1: An Important Mechanism of Arsenic Trioxide-Induced Long QT Syndrome
- (2018) Yanan Jiang et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Oral arsenic plus retinoic acid versus intravenous arsenic plus retinoic acid for non-high-risk acute promyelocytic leukaemia: a non-inferiority, randomised phase 3 trial
- (2018) Hong-Hu Zhu et al. LANCET ONCOLOGY
- The impact of oral arsenic and all-trans-retinoic acid on coagulopathy in acute promyelocytic leukemia
- (2018) Hong-Hu Zhu et al. LEUKEMIA RESEARCH
- Arsenic trioxide and sorafenib induce synthetic lethality of FLT3-ITD acute myeloid leukemia cells
- (2018) Rui Wang et al. MOLECULAR CANCER THERAPEUTICS
- Salvianolic Acid A Ameliorates Arsenic Trioxide-Induced Cardiotoxicity Through Decreasing Cardiac Mitochondrial Injury and Promotes Its Anticancer Activity
- (2018) Jing-yi Zhang et al. Frontiers in Pharmacology
- Multicenter randomized trial of arsenic trioxide and Realgar-Indigo naturalis formula in pediatric patients with acute promyelocytic leukemia: interim results of the SCCLG-APL clinical study
- (2018) Ming-Hua Yang et al. AMERICAN JOURNAL OF HEMATOLOGY
- Arsenic targets Pin1 and cooperates with retinoic acid to inhibit cancer-driving pathways and tumor-initiating cells
- (2018) Shingo Kozono et al. Nature Communications
- Combination of ATO with FLT3 TKIs eliminates FLT3/ITD+ leukemia cells through reduced expression of FLT3
- (2018) Kozo Nagai et al. Oncotarget
- Combination of arsenic trioxide and Dasatinib: a new strategy to treat Philadelphia chromosome-positive acute lymphoblastic leukaemia
- (2017) Tao Wang et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Salvianolic acid A, a novel PI3K/Akt inhibitor, induces cell apoptosis and suppresses tumor growth in acute myeloid leukemia
- (2017) Renzhi Pei et al. LEUKEMIA & LYMPHOMA
- Auraptene Induces Apoptosis via Myeloid Cell Leukemia 1-Mediated Activation of Caspases in PC3 and DU145 Prostate Cancer Cells
- (2017) Jae Chul Lee et al. PHYTOTHERAPY RESEARCH
- Synergistic inhibition of leukemia WEHI-3 cell growth by arsenic trioxide and Hedyotis diffusa Willd extract in vitro and in vivo
- (2017) Yu-Jui Kuo et al. Experimental and Therapeutic Medicine
- Long-term outcome of acute promyelocytic leukemia treated with all- trans -retinoic acid, arsenic trioxide, and gemtuzumab
- (2016) Yasmin Abaza et al. BLOOD
- Transposon Mutagenesis Reveals Fludarabine Resistance Mechanisms in Chronic Lymphocytic Leukemia
- (2016) T. Pandzic et al. CLINICAL CANCER RESEARCH
- Arsenic trioxide augments all- trans retinoic acid-induced differentiation of HL-60 cells
- (2016) Daigo Sumi et al. LIFE SCIENCES
- Arsenic trioxide synergistically potentiates the cytotoxic effect of fludarabine in chronic lymphocytic leukemia cells by further inactivating the Akt and ERK signaling pathways
- (2015) Carol Lozano-Santos et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Retinoic acid and arsenic trioxide trigger degradation of mutated NPM1, resulting in apoptosis of AML cells
- (2015) H. El Hajj et al. BLOOD
- Tamibarotene in patients with acute promyelocytic leukaemia relapsing after treatment with all-transretinoic acid and arsenic trioxide
- (2015) David Sanford et al. BRITISH JOURNAL OF HAEMATOLOGY
- The effect of nilotinib plus arsenic trioxide on the proliferation and differentiation of primary leukemic cells from patients with chronic myoloid leukemia in blast crisis
- (2015) Wei Wang et al. Cancer Cell International
- The mechanism of synergistic effects of arsenic trioxide and rapamycin in acute myeloid leukemia cell lines lacking typical t(15;17) translocation
- (2015) Vilma Dembitz et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Arsenic trioxide and all-trans retinoic acid treatment for acute promyelocytic leukaemia in all risk groups (AML17): results of a randomised, controlled, phase 3 trial
- (2015) Alan K Burnett et al. LANCET ONCOLOGY
- Reduced medical costs and hospital days when using oral arsenic plus ATRA as the first-line treatment of acute promyelocytic leukemia
- (2015) Hao Jiang et al. LEUKEMIA RESEARCH
- Acute promyelocytic leukemia with isochromosome 17q and cryptic PML-RARA successfully treated with all-trans retinoic acid and arsenic trioxide
- (2015) Daniel Shepshelovich et al. Cancer Genetics
- Adding ascorbic acid to arsenic trioxide produces limited benefit in patients with acute myeloid leukemia excluding acute promyelocytic leukemia
- (2014) Ibrahin Aldoss et al. ANNALS OF HEMATOLOGY
- Up-regulation of miR-21 and miR-23a Contributes to As2O3-induced hERG Channel Deficiency
- (2014) Xin Zhao et al. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
- BIMELis a key effector molecule in oxidative stress-mediated apoptosis in acute myeloid leukemia cells when combined with arsenic trioxide and buthionine sulfoximine
- (2014) Yukie Tanaka et al. BMC CANCER
- Resveratrol enhances the suppressive effects of arsenic trioxide on primitive leukemic progenitors
- (2014) Edward J Wu et al. CANCER BIOLOGY & THERAPY
- The growth-inhibitory and apoptosis-inducing effect of deferoxamine combined with arsenic trioxide on HL-60 xenografts in nude mice
- (2014) Runhong Yu et al. LEUKEMIA RESEARCH
- Src family kinase inhibitor PP2 enhances differentiation of acute promyelocytic leukemia cell line induced by combination of all-trans-retinoic acid and arsenic trioxide
- (2014) Yun Seok Jung et al. LEUKEMIA RESEARCH
- Arsenic Trioxide and Resveratrol Show Synergistic Anti-Leukemia Activity and Neutralized Cardiotoxicity
- (2014) Yuhua Fan et al. PLoS One
- Resveratrol protects against arsenic trioxide-induced nephrotoxicity by facilitating arsenic metabolism and decreasing oxidative stress
- (2013) Meiling Yu et al. ARCHIVES OF TOXICOLOGY
- The Protective Role of Resveratrol against Arsenic Trioxide-Induced Cardiotoxicity
- (2013) Weiqian Zhang et al. Evidence-based Complementary and Alternative Medicine
- Oral Tetra-Arsenic Tetra-Sulfide Formula Versus Intravenous Arsenic Trioxide As First-Line Treatment of Acute Promyelocytic Leukemia: A Multicenter Randomized Controlled Trial
- (2013) Hong-Hu Zhu et al. JOURNAL OF CLINICAL ONCOLOGY
- Src Family Kinase Inhibitor PP2 Has Different Effects on All-Trans-Retinoic Acid or Arsenic Trioxide-Induced Differentiation of an Acute Promyelocytic Leukemia Cell Line
- (2013) Suk-Gu Yoon et al. Cancer Research and Treatment
- Sorafenib treatment of FLT3-ITD+ acute myeloid leukemia: favorable initial outcome and mechanisms of subsequent nonresponsiveness associated with the emergence of a D835 mutation
- (2012) C. H. Man et al. BLOOD
- Resveratrol attenuates hepatotoxicity of rats exposed to arsenic trioxide
- (2012) Weiqian Zhang et al. FOOD AND CHEMICAL TOXICOLOGY
- Upregulation of microRNA-1 and microRNA-133 contributes to arsenic-induced cardiac electrical remodeling
- (2012) Hongli Shan et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Mutations of FLT3/ITD confer resistance to multiple tyrosine kinase inhibitors
- (2012) A B Williams et al. LEUKEMIA
- The non-steroidal anti-inflammatory drugs Sulindac sulfide and Diclofenac induce apoptosis and differentiation in human acute myeloid leukemia cells through an AP-1 dependent pathway
- (2011) Raminder Singh et al. APOPTOSIS
- Phase 1 study of arsenic trioxide, high-dose cytarabine, and idarubicin to down-regulate constitutive signal transducer and activator of transcription 3 activity in patients aged
- (2011) Meir Wetzler et al. CANCER
- Assessment of the involvement of oxidative stress and Mitogen-Activated Protein Kinase signaling pathways in the cytotoxic effects of arsenic trioxide and its combination with sulindac or its metabolites: sulindac sulfide and sulindac sulfone on human leukemic cell lines
- (2011) M. Stępnik et al. MEDICAL ONCOLOGY
- Oral arsenic trioxide for relapsed acute promyelocytic leukemia in pediatric patients
- (2011) Wing Y. Au et al. PEDIATRIC BLOOD & CANCER
- Sulindac and its metabolites: Sulindac sulfide and sulindac sulfone enhance cytotoxic effects of arsenic trioxide on leukemic cell lines
- (2011) Maciej Stępnik et al. TOXICOLOGY IN VITRO
- Synergistic antiproliferative effect of arsenic trioxide combined with bortezomib in HL60 cell line and primary blasts from patients affected by myeloproliferative disorders
- (2010) Martina Canestraro et al. CANCER GENETICS AND CYTOGENETICS
- Induction of B-Chronic Lymphocytic Leukemia Cell Apoptosis by Arsenic Trioxide Involves Suppression of the Phosphoinositide 3-Kinase/Akt Survival Pathway via c-jun-NH2 Terminal Kinase Activation and PTEN Upregulation
- (2010) J. Redondo-Munoz et al. CLINICAL CANCER RESEARCH
- Gefitinib enhances arsenic trioxide (AS2O3)-induced differentiation of acute promyelocytic leukemia cell line
- (2010) Eui-Kyu Noh et al. LEUKEMIA RESEARCH
- Synergistic mitosis-arresting effects of arsenic trioxide and paclitaxel on human malignant lymphocytes
- (2009) Xu-Fang Duan et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Frequent genomic abnormalities in acute myeloid leukemia/myelodysplastic syndrome with normal karyotype
- (2009) T. Akagi et al. HAEMATOLOGICA
- Long-term efficacy and safety of all-trans retinoic acid/arsenic trioxide-based therapy in newly diagnosed acute promyelocytic leukemia
- (2009) J. Hu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Arsenic Trioxide-Induced Apoptosis in H9c2 Cardiomyocytes: Implications in Cardiotoxicity
- (2008) Xiaoyan Zhao et al. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
- Acute promyelocytic leukemia: from highly fatal to highly curable
- (2008) Z.-Y. Wang et al. BLOOD
- N-(β-Elemene-13-yl)tryptophan methyl ester induces apoptosis in human leukemia cells and synergizes with arsenic trioxide through a hydrogen peroxide dependent pathway
- (2008) Zhiying Yu et al. CANCER LETTERS
- Gene mutations and response to treatment with all-trans retinoic acid in elderly patients with acute myeloid leukemia. Results from the AMLSG Trial AML HD98B
- (2008) R. F. Schlenk et al. HAEMATOLOGICA
- Arsenic trioxide induces apoptosis preferentially in B-CLL cells of patients with unfavourable prognostic factors including del17p13
- (2008) Olaf Merkel et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Apoptosis induction by (+)α-tocopheryl succinate in the absence or presence of all-trans retinoic acid and arsenic trioxide in NB4, NB4-R2 and primary APL cells
- (2008) Rosana Aparecida Freitas et al. LEUKEMIA RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now